ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 757098 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 757098; 2) Community: the network communities that were significantly associated with the response to NSC 757098; 3) Molecule: the relationships between components within communities and NSC 757098; 4) MDR: the compounds that were significantly associated with the NSC 757098.

NSC Compound Enrichment Correlation
NSC 681633 Camptothecin Derivative 0.0114553853234977 0.67958817
NSC 681641 Camptothecin Derivative 0.0114553853234977 0.61779003
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0114553853234977 0.44744201
NSC 694075 Null 0.0114553853234977 0.28660673
NSC 703468 Null 0.0114553853234977 0.23392849
NSC 704657 Null 0.0114553853234977 0.43414659
NSC 707085 Null 0.0114553853234977 0.17755647
NSC 715974 Null 0.0114553853234977 0.33266193
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0114553853234977 0.7064647
NSC 728133 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,5-dichlorobenzene 0.0114553853234977 0.50722326
Total:93  Current:29    [First] [Prev] [Next] [Last]